Cristian Serafinceanu

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 292 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · Diabetes Care · 2018 · 238 citations

Medicine, Pharmacology, Pharmacotherapy +17

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

Guntram Schernthaner, Naim Shehadeh, Anna Bazarova et al. · Cardiovascular Diabetology · 2020 · 160 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Prevalence of diabetes mellitus and prediabetes in the adult <scp>R</scp>omanian population: <scp>PREDATORR</scp> study

Maria Moța, Simona Georgiana Popa, Eugen Moța et al. · Journal of Diabetes · 2015 · 142 citations

Medicine, Endocrinology, Health Sciences +13

Prevalence of overweight/obesity, abdominal obesity and metabolic syndrome and atypical cardiometabolic phenotypes in the adult Romanian population: PREDATORR study

Simona Georgiana Popa, Maria Moța, Adina Popa et al. · Journal of Endocrinological Investigation · 2016 · 79 citations

Medicine, Endocrinology, Epidemiology +6